Author:
Gerna Giuseppe,Sarasini Antonella,Baldanti Fausto,Percivalle Elena,Zella Davide,Revello Maria Grazia
Reference24 articles.
1. Baldanti, F., Underwood, M., Stanat, S.E. et al. (1996) Single aminoacid changes in UL54 confer foscarnet resistance and slow-growth phenotype while UL97 mutations confer ganciclovir resistance in three double resistant human cytomegalovirus (HCMV) strains recovered from AIDS patients. J. Virol. 70, 1390–1395.
2. Bergdahl, S., Sonnerborg, A., Larsson, A. and Strannegard, O. (1988) Declining levels of HIV p24 antigen in serum during treatment with foscarnet. Lancet 1, 1052.
3. Blanshard, C., Benhamou, Y., Dohin, E., Lernestedt, J-O, Gazzard, B.G. and Katlama, C. (1995) Treatment of AIDS—associated gastrointestinal cytomegalovirus infection with foscarnet and ganciclovir: a randomized comparison. J. Infect. Dis. 172, 622–628.
4. Clayton, F., Klein, E.B. and Kotler, D.P. (1989) Correlation of in situ hybridization with histology and viral culture in patients with acquired immunodeficiency syndrome with cytomegalovirus colitis. Arch. Pathol. Lab. Med. 113, 1124–1126.
5. Cotte, L., Drouet, E., Bissuel, F., Denoyel, G.A. and Trepo, C. (1993) Diagnostic value of amplification of human cytomegalovirus DNA from gastrointestinal biopsies from human immunodeficiency virus infected patients. J. Clin. Microbiol. 31, 2066–2069.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Preferred Therapy for Specific Viral Pathogens;2024 Nelson’s Pediatric Antimicrobial Therapy;2024-02-12
2. Preferred Therapy for Specific Viral Pathogens;2023 Nelson’s Pediatric Antimicrobial Therapy;2023-03-01
3. Antiviral Agents;Principles and Practice of Pediatric Infectious Diseases;2018
4. Antiviral Agents;Principles and Practice of Pediatric Infectious Diseases;2012
5. Human cytomegalovirus load measurement and its applications for pre-emptive therapy in patients undergoing hematopoietic stem cell transplantation;Hematological Oncology;2008-09